People

Jeff Bush, PhD studies signaling during normal craniofacial development and in cases of craniofacial birth defects with the goal of developing preventive therapies.

Marcelle Cedars, MD is the Director of the Division of Reproductive Endocrinology and Infertility and the UCSF Reproductive Health Clinic. She studies ovarian aging, polycystic ovarian syndrome, and assisted reproductive methods in clinical and basic studies.

Alice Chan, MD, PhD studies pathways of immune development and regulation in the context of pediatric immune regulatory disorders.

Pao-Tien Chuang, MD, PhD studies Hedgehog signaling in mammalian embryogenesis and postnatal physiology.

Claire Clelland, MD, PhD, MPhil aims to develop novel therapies for dementia and related neurodegenerative diseases. Her lab works to create new CRISPR gene editing approaches in human iPSC-derived cell types relevant to disease. They also work to build cell model systems that more faithfully replicate human disease.

Kelsey Collins, PhD, uses induced pluripotent stem cells, CRISPR-Cas9 genome engineering, mouse models, human tissues, and state-of-the-art multi-omic spatial approaches to define mechanisms and create therapies that have implications for aging, obesity, diabetes, and other chronic diseases.

Bruce Conklin, MD is a senior investigator at the Gladstone Institute of Cardiovascular Disease. His research focuses on genes involved in abnormal heart rhythms and heart failure with the goal of developing better, more personalized heart drugs. 

Marco Conti, MD focuses on signal transduction required for germ cell development.

Joseph Costello, PhD studies the onset of tumorigenesis with an emphasis on discovering the mechanisms by which genes accumulate changes that may activate or inactivate tumor genes.

Mort Cowan, MD studies the definitive treatment of children with primary immune deficiencies using hematopoietic stem cells while also running a first-in-human trial of lentiviral mediated gene insertion into autologous stem cells to correct the immune deficiency in Artemis-deficient Severe Combined Immunodeficiency (ART-SCID).

Kyle Cromer, PhD focuses on using genome editing to engineer erythropoiesis for clinical applications.

Elizabeth "Betsy" Crouch, MD, PhD is a neonatologist, neuroscientist, and vascular biologist who studies neurovascular development. The lab employs single cell omics, flow cytometry, and organoid models to study human brain blood vessel cells during development.